Sound View Wealth Advisors Group, LLC Krystal Biotech, Inc. Transaction History
Sound View Wealth Advisors Group, LLC
- $1.23 Billion
- Q4 2024
A detailed history of Sound View Wealth Advisors Group, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Sound View Wealth Advisors Group, LLC holds 1,420 shares of KRYS stock, worth $219,915. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,420
Previous 1,200
18.33%
Holding current value
$219,915
Previous $218,000
1.83%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
307Shares Held
24.4MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$611 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$441 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$406 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$225 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$153 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.97B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...